Provided by Tiger Fintech (Singapore) Pte. Ltd.

Q32 Bio Inc.

2.00
+0.16008.70%
Post-market: 2.000.00000.00%16:05 EDT
Volume:121.08K
Turnover:237.01K
Market Cap:24.40M
PE:-0.30
High:2.01
Open:1.85
Low:1.85
Close:1.84
Loading ...

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires Live
·
12 Dec 2024

Q32 Bio Shares Plummet After Downgrades, Price Target Cuts

MT Newswires Live
·
12 Dec 2024

Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations

Benzinga
·
11 Dec 2024

Q32 Bio downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
11 Dec 2024

Raymond James Downgrades Q32 Bio to Outperform From Strong Buy, Adjusts Price Target to $22 From $90

MT Newswires Live
·
11 Dec 2024

US Consumer Prices Rise in Line With Expectations in November as US Equity Futures Rise Pre-Bell

MT Newswires Live
·
11 Dec 2024

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday as Investors Anticipate Latest Inflation Data

MT Newswires Live
·
11 Dec 2024

BUZZ-Q32 Bio tumbles after mid-stage trial setback for dermatitis drug

Reuters
·
11 Dec 2024

Q32 Bio Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
11 Dec 2024

Q32 Bio Inc : Wells Fargo Cuts to Equal Weight From Overweight; Cuts Target Price to $16 From $95

THOMSON REUTERS
·
11 Dec 2024

Q32 Bio (QTTB) Receives a Buy from Oppenheimer

TIPRANKS
·
11 Dec 2024

Q32 Bio Inc : Raymond James Cuts to Outperform From Strong Buy; Cuts Target Price to $22 From $90

THOMSON REUTERS
·
11 Dec 2024

Q32 Bio Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
11 Dec 2024

Q32 Bio Shares Drop 65.4% Premarket After Co's Dermatitis Drug Fails in Part of a Study

THOMSON REUTERS
·
11 Dec 2024

Q32 Bio price target lowered to $20 from $85 at Piper Sandler

TIPRANKS
·
11 Dec 2024

Q32 Bio Inc : Leerink Partners Cuts to Market Perform From Outperform

THOMSON REUTERS
·
11 Dec 2024